Lantern Pharma Inc
LTRN
Company Profile
Business description
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group’s growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
Contact
1920 McKinney Avenue
7th Floor
DallasTX75201
USAT: +1 972 277-1136
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
24
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,715.80 | 25.60 | -0.29% |
| CAC 40 | 7,553.45 | 102.67 | -1.34% |
| DAX 40 | 23,057.38 | 260.43 | -1.12% |
| Dow JONES (US) | 42,171.66 | 44.14 | -0.10% |
| FTSE 100 | 8,791.80 | 51.67 | -0.58% |
| HKSE | 23,474.81 | 237.07 | 1.02% |
| NASDAQ | 19,546.27 | 25.18 | 0.13% |
| Nikkei 225 | 38,480.86 | 7.48 | -0.02% |
| NZX 50 Index | 12,569.05 | 58.27 | -0.46% |
| S&P 500 | 5,980.87 | 1.85 | -0.03% |
| S&P/ASX 200 | 8,496.40 | 27.30 | -0.32% |
| SSE Composite Index | 3,364.83 | 2.73 | 0.08% |